Dupuytren's disease A clinical series demonstrating softening and flattening of hypertrophic scars and keloids by the intralesional injection of triamcinolone acetonide was published in 1966
Dupuytren's disease is a benign nodular fibromatosis, affecting the hands, named after
The purpose of this study was to determine whether intralesional injections
A retrospective review of 63 patients (75 hands) with early Dupuytren’s disease is the largest available to date (Ketchum and Donahue, 2000)
Intralesional injections of triamcinolone acetonide into the palmar nodule was done for a total of four times during three months but showed no improvement in the contractures Dupuytren’s contracture is a common condition that has the potential to be debilitating
Trojian and Chu describe a procedure for injecting lidocaine 2% (Xylocaine) followed by triamcinolone acetonide (Kenalog) for the Over a 4-year period 63 patients (75 hands) with Dupuytren's nodules were treated with a series of injections with the steroid triamcinolone acetonide directly into the area of disease
To date, only one pharmacotherapy (clostridial collagenase) has been approved for use in Dupuytren disease
A retrospective review of 63 patients (75 hands) with early Dupuytren’s disease is the largest available to date (Ketchum and Donahue, 2000)
The webinars we have done are: 1/ Dupuytren’s disease and surgical treatments
6/ A video on surgical options for Peyronie’s Disease
Over a 4-year period 63 patients (75 hands) with Dupuytren's nodules were treated with a series of injections with the steroid triamcinolone acetonide directly into the area of disease
J Hand Surg Am
Injections of triamcinolone acetonide have been reported to resolve keloids and hypertrophic scars by 50%
97% (62/63) of patients experienced The injection of nodules of Dupuytren's disease with triamcinalone acetonide
Triamcinolone acetonide injections were studied as primary treatment in 63 patients (60% male sex; average age 55 years) with Dupuytren’s nodules
of intralesional fenestration and corticosteroid injection for symptomatic plantar fibromatosis using a mixture of triamcinolone acetonide (20 Kenalog-40 Injection (triamcinolone acetonide injectable suspension, USP) is a synthetic glucocorticoid corticosteroid with anti-inflammatory action